Hoth Therapeutics, Inc. has addressed recent market rumors regarding its exposure to digital assets such as Bitcoin, Solana, and Ethereum. The company clarified that it holds no cryptocurrency assets and that its maximum exposure to such assets over the last year did not exceed $350,000. Hoth emphasized its ongoing commitment to advancing its clinical trials and progressing its therapeutic pipeline, particularly in oncology and obesity.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hoth Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY80717) on February 05, 2026, and is solely responsible for the information contained therein.